Aurobindo Pharma Usa
UEI: MU7KBS6E6L25
• CAGE: 43VQ4
Overview
Parent Awardee
Name
Aurobindo Pharma Usa
Headquarters
East Windsor, NJ
United States
United States
Most Recent Award
March 15, 2020
Calculating
Federal contract recipient
AUROBINDO PHARMA USA INC
dba AUROBINDO PHARMA U S A INC
(UEI MU7KBS6E6L25, CAGE 43VQ4)
is headquartered in East Windsor NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in February 2004 and
federally registered in
August 2005.
Federal Award Analysis
Aurobindo Pharma Usa federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
AUROBINDO PHARMA USA INC
DBA
AUROBINDO PHARMA U S A INC
UEI
MU7KBS6E6L25
CAGE Code
43VQ4
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 26, 2004
Initial Registration
Aug. 29, 2005
Last Registration
Dec. 24, 2025
Registration Activation
Dec. 24, 2025
Registration Expiration
Dec. 22, 2026
Fiscal Year End
March 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Aurobindo Pharma Usa
GSA Schedules and Price Lists
- Aurobindo Pharma Usa
- PoP: 3/14/20 - 3/15/27
- Type: Pharmaceuticals and Drugs (FSS 65 I B)